Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals

Talia Kustin, Noam Harel, Uriah Finkel, Shay Perchik, Sheri Harari, Maayan Tahor, Itamar Caspi, Rachel Levy, Michael Leschinsky, Shifra Ken Dror, Galit Bergerzon, Hala Gadban, Faten Gadban, Eti Eliassian, Orit Shimron, Loulou Saleh, Haim Ben-Zvi, Doron Amichay, Anat Ben-Dor, Dana Sagas, Merav Strauss, Yonat Shemer Avni, Amit Huppert, Eldad Kepten, Ran D. Balicer, Doron Nezer, Shay Ben-Shachar, Adi Stern
doi: https://doi.org/10.1101/2021.04.06.21254882

Article Information

doi 
https://doi.org/10.1101/2021.04.06.21254882
History 
  • April 9, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Talia Kustin*,1,2,
  2. Noam Harel*,1,2,
  3. Uriah Finkel3,
  4. Shay Perchik3,
  5. Sheri Harari1,2,
  6. Maayan Tahor1,
  7. Itamar Caspi1,
  8. Rachel Levy1,
  9. Michael Leschinsky3,
  10. Shifra Ken Dror4,
  11. Galit Bergerzon4,
  12. Hala Gadban4,
  13. Faten Gadban4,
  14. Eti Eliassian5,
  15. Orit Shimron5,
  16. Loulou Saleh6,
  17. Haim Ben-Zvi6,
  18. Doron Amichay7,8,
  19. Anat Ben-Dor7,
  20. Dana Sagas9,
  21. Merav Strauss9,
  22. Yonat Shemer Avni10,11,
  23. Amit Huppert12,13,
  24. Eldad Kepten3,
  25. Ran D. Balicer3,
  26. Doron Nezer14,*,
  27. Shay Ben-Shachar3,13,*,† and
  28. Adi Stern1,2,†
  1. 1The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
  2. 2Edmond J. Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv, Israel
  3. 3Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel
  4. 4Clalit Health Services, Central Laboratories, Haifa and Western Galilee, Israel
  5. 5Progenin Laboratories, Jerusalem District, Clalit Health Services, Israel
  6. 6Microbiology lab, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
  7. 7Central Laboratory, Clalit Health Services, Tel Aviv, Israel
  8. 8Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University, Beersheba, Israel
  9. 9Microbiology Laboratory, Emek Medical Center, Afula, Israel
  10. 10Laboratory of Clinical Virology, Soroka University Medical Center. Beersheba, Israel
  11. 11Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba, Israel
  12. 12The Bio-statistical and Bio-mathematical Unit, The Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel
  13. 13The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  14. 14Clalit Health Services, Tel Aviv, Israel
  1. ↵†Corresponding authors: shayb{at}clalit.org.il, sternadi{at}tauex.tau.ac.il

  1. ↵* These authors contributed equally

Back to top
Posted April 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Talia Kustin, Noam Harel, Uriah Finkel, Shay Perchik, Sheri Harari, Maayan Tahor, Itamar Caspi, Rachel Levy, Michael Leschinsky, Shifra Ken Dror, Galit Bergerzon, Hala Gadban, Faten Gadban, Eti Eliassian, Orit Shimron, Loulou Saleh, Haim Ben-Zvi, Doron Amichay, Anat Ben-Dor, Dana Sagas, Merav Strauss, Yonat Shemer Avni, Amit Huppert, Eldad Kepten, Ran D. Balicer, Doron Nezer, Shay Ben-Shachar, Adi Stern
medRxiv 2021.04.06.21254882; doi: https://doi.org/10.1101/2021.04.06.21254882
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area